drugset / Trial / NCT02759224

A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet

NCT02759224

Phase 1 Completed 34 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

An Open-Label, Randomized, Single-dose, 2x2 Crossover Study to Compare the Pharmacokinetics of BRI-1501 Tablet and Coadministration of Lafutidine and Irsogladine maleate as Individual Tablets in Healthy Adult Volunteers

Timeline

Start
2016-04-15
Primary completion
2016-07-01
Completion
2016-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject BRI-1501 Unknown
Subject Irsogladine Small molecule
Subject Lafutidine Small molecule

Indications